Insider Transactions

What Durata Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Shannon John Patrick Jr	Chief Commercial Officer	Nov 17	Disposition to Issuer · D	−11,000	—	—	0
Domain Associates	10% owner	Nov 17	Disposition to Issuer · D	−6,250	—	—	0
Oboyle Kevin C	Director	Nov 17	Disposition to Issuer · D	−5,000	—	—	0
Canaan Viii Lp	Director	Nov 17	Disposition to Issuer · D	−5,034	—	—	0
Canaan Viii Lp	Director	Nov 17	Tender Offer · U	−1,902,030	—	—	0
New Leaf Ventures II, L.p.	10% owner	Nov 17	Disposition to Issuer · D	−3,028,439	—	—	0
Dp Viii Associates, L.p.	10% owner	Nov 17	Disposition to Issuer · D	−22,306	—	—	0
Domain Partners VIII, L.p.	10% owner	Nov 17	Disposition to Issuer · D	−3,006,132	—	—	0
Dunne Michael W.	Chief Medical Officer	Nov 17	Disposition to Issuer · D	−13,220	—	—	0
Edick Paul R	Chief Executive Officer	Nov 17	Disposition to Issuer · D	−500	—	—	0
Edick Paul R	Chief Executive Officer	Nov 17	Disposition to Issuer · D	−45,636	—	—	0
Fishman Corey N.	CFO&COO	Nov 17	Disposition to Issuer · D	−24,941	—	—	0
De Schutter Richard U	Director	Nov 17	Disposition to Issuer · D	−12,500	—	—	0
De Schutter Richard U	Director	Nov 17	Disposition to Issuer · D	−15,000	—	—	0
Giles Lisa M.	Director	Nov 17	Disposition to Issuer · D	−2,500	—	—	0
Ahrens Brenton Karl	Director	Nov 17	Disposition to Issuer · D	−5,034	—	—	0
Ahrens Brenton Karl	Director	Nov 17	Tender Offer · U	−1,902,030	—	—	0
Canaan Viii Lp	Director	Aug 26	Exercise / conversion · M	+5,034	$2.08	+$10.5K	5,034
Canaan Viii Lp	Director	Aug 26	Exercise / conversion · M	+5,034	$2.08	+$10.5K	5,034
Ahrens Brenton Karl	Director	Aug 26	Exercise / conversion · M	+5,034	$2.08	+$10.5K	5,034

Page 1 of 5 · showing the 20 most recent Sign up free to view all 89 transactions and filter by insider →

Comments